Clinical trial
Transplantation of Umbilical Cord Blood in Patients With Hematological Malignancies Using a Treosulfan Based Preparative Regimen
NCT00796068 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transplantation of Umbilical Cord Blood in Patients With Hematological Malignancies Using a Treosulfan Based Preparative Regimen
- Lead sponsor
- Fred Hutchinson Cancer Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 24, 2009
- Completion date
- December 14, 2021
- Enrollment
- 130 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
acute biphenotypic leukemia, acute lymphoblastic leukemia in remission, acute myeloid leukemia in remission, blasts under 5 percent of bone marrow nucleated cells, chronic myelogenous leukemia, bcr-abl1 positive, chronic phase chronic myelogenous leukemia, bcr-abl1 positive, myelodysplastic syndrome (mds)